Related references
Note: Only part of the references are listed.Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response
Fei-Fei Hu et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells
Farsaneh Sadeghlar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis
Giammauro Berardi et al.
JOURNAL OF HEPATOLOGY (2020)
Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
Sureerat Padthaisong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Tumor intrinsic and extrinsic immune functions of CD155
Jake. S. O'Donnell et al.
SEMINARS IN CANCER BIOLOGY (2020)
Prognostic value of immune checkpoint molecules in breast cancer
Jun Fang et al.
BIOSCIENCE REPORTS (2020)
Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
Yongfu Xiong et al.
FRONTIERS IN GENETICS (2020)
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Ahmed Sadik et al.
CELL (2020)
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi et al.
EMBO MOLECULAR MEDICINE (2020)
An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival
Sheng Dong et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma
Xun Xu et al.
JOURNAL OF HEPATOLOGY (2019)
Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
Dong Zhang et al.
FRONTIERS IN GENETICS (2019)
Alternative Splicing in Angiogenesis
Elizabeth Bowler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1
Muhammad Suleman et al.
CELL CYCLE (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
Hua-Yu Wu et al.
ONCOLOGY LETTERS (2019)
Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
Megan Stevens et al.
FRONTIERS IN GENETICS (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer
Raheleh Amirkhah et al.
CELLS (2019)
Functional and Phenotypic Characterization of Tumor-Infiltrating Leukocyte Subsets and Their Contribution to the Pathogenesis of Hepatocellular Carcinoma and Cholangiocarcinoma
C. Martin-Sierra et al.
TRANSLATIONAL ONCOLOGY (2019)
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Lele Ye et al.
FRONTIERS IN IMMUNOLOGY (2019)
IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer
Hasanthi C. de Silva et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
The role of alternative splicing in cancer drug resistance
Zahava Siegfried et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ
Youmao Tao et al.
JOURNAL OF CANCER (2018)
Alternative Splicing in the Hippo Pathway-Implications for Disease and Potential Therapeutic Targets
Sean Porazinski et al.
GENES (2018)
miR-487a promotes progression of gastric cancer by targeting TIA1
Xuefeng Yang et al.
BIOCHIMIE (2018)
A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma
Junyu Long et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
The immune checkpoint, HVEM may contribute to immune escape in non small cell lung cancer lacking PD-L1 expression
Shengxiang Ren et al.
LUNG CANCER (2018)
Alternative splicing in prostate cancer
Alec Paschalis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data
Yongfu Xiong et al.
EBIOMEDICINE (2018)
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
Prachi Mishra et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation
Eun Kyung Kim et al.
GASTRIC CANCER (2017)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
Chang-Yi Lu et al.
ONCOTARGET (2017)
End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer
Jolyn S. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
Yanqing Liu et al.
MOLECULAR CANCER (2017)
TIA-1 RRM23 binding and recognition of target oligonucleotides
Saboora Waris et al.
NUCLEIC ACIDS RESEARCH (2017)
UpSetR: an R package for the visualization of intersecting sets and their properties
Jake R. Conway et al.
BIOINFORMATICS (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
TCGASpliceSeq a compendium of alternative mRNA splicing in cancer.
Michael Ryan et al.
NUCLEIC ACIDS RESEARCH (2016)
A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma
Li Zhang et al.
ONCOTARGET (2016)
Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells
Renyu Lin et al.
CANCER LETTERS (2016)
Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing
Xinping Yang et al.
CELL (2016)
Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma
Junichi Hamada et al.
ONCOTARGET (2016)
A New Laboratory-Based Algorithm to Predict Development of Hepatocellular Carcinoma in Patients With Hepatitis C and Cirrhosis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma Systematic Review and Meta-analysis
Michael N. Mavros et al.
JAMA SURGERY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
SpliceAid-F: a database of human splicing factors and their RNA-binding sites
Matteo Giulietti et al.
NUCLEIC ACIDS RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
SpliceAid 2: A Database of Human Splicing Factors Expression Data and RNA Target Motifs
Francesco Piva et al.
HUMAN MUTATION (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease
S. Behboudi et al.
BRITISH JOURNAL OF CANCER (2010)
Circos: An information aesthetic for comparative genomics
Martin Krzywinski et al.
GENOME RESEARCH (2009)
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma
Xin-Da Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Inhibition of the IFN-β Response in Hepatocellular Carcinoma by Alternative Spliced Isoform of IFN Regulatory Factor-3
Sabrina Marozin et al.
MOLECULAR THERAPY (2008)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)